The present disclosure describes bis-modified bicyclic nucleosides and oligomeric compounds that can be prepared comprising at least one of these bis-modified bicyclic nucleosides. More particularly, the bis-modified bicyclic nucleosides have at least one substituent group at the 5'-methylene and on the bridge methylene and can be chiral. These bis-modified bicyclic nucleosides are expected to be useful for enhancing one or more property of oligomeric compounds including for example enhancing nuclease resistance.
Claims What is claimed is: 1. An oligomeric compound having the formula: G-[T-L].sub.j-[R-L].sub.q-R-[L-T].sub.r-E wherein: each T is a monomer of Formula V: ##STR00038## wherein independently for each monomer having Formula V: Bx is a heterocyclic base moiety; one of Z.sub.1 and Z.sub.2 is H, C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl or substituted C.sub.2-C.sub.6 alkynyl and the other one of Z.sub.1 and Z.sub.2 is C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl or substituted C.sub.2-C.sub.6 alkynyl; one of Q.sub.1 and Q.sub.2 is H, C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, substituted C.sub.2-C.sub.6 alkynyl, thiol or substituted thiol and the other one of Q.sub.1 and Q.sub.2 is C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, substituted C.sub.2-C.sub.6 alkynyl, thiol or substituted thiol; or Q.sub.1 and Q.sub.2 together are methylene (.dbd.CH.sub.2); each R is a .beta.-D-2'-deoxyribonucleoside; each L is an internucleoside linking group; G and E are each, independently, H, a hydroxyl protecting group, a linked conjugate group or a 5' or 3'-terminal group; wherein each substituted group is mono or poly substituted with substituent groups independently selected from halogen, OJ.sub.1, SJ.sub.1, NJ.sub.1J.sub.2, N.sub.3, COOJ.sub.1, CN, O--C(.dbd.O)NJ.sub.1J.sub.2, N(H)C(.dbd.NH)NJ.sub.1J.sub.2, N(H)C(.dbd.O)N(H)J.sub.2 or N(H)C(.dbd.S)N(H)J.sub.2; each J.sub.1 and J.sub.2 is, independently, H, C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl, C.sub.1-C.sub.6 aminoalkyl or a protecting group; q is from 7 to about 15; j is 0 or from 1 to about 5; r is 0 or from 1 to about 5; and the sum of j and r is at least 1. 2. The oligomeric compound of claim 1 wherein for each monomer having Formula V, Z.sub.1 or Z.sub.2 is H and the other of Z.sub.1 and Z.sub.2 is C.sub.1-C.sub.6 alkyl, substituted C.sub.1-C.sub.6 alkyl, C.sub.2-C.sub.6 alkenyl, substituted C.sub.2-C.sub.6 alkenyl, C.sub.2-C.sub.6 alkynyl or substituted C.sub.2-C.sub.6 alkynyl. 3. The oligomeric compound of claim 2 wherein the other of Z.sub.1 and Z.sub.2 is CH.sub.2F, CHF.sub.2 or CF.sub.3. 4. The oligomeric compound of claim 2 wherein the other of Z.sub.1 and Z.sub.2 is C.sub.1-C.sub.6 alkyl or substituted C.sub.1-C.sub.6 alkyl. 5. The oligomeric compound of claim 2 wherein the other of Z.sub.1 and Z.sub.2 is CH.sub.3. 6. The oligomeric compound of claim 1 wherein for each monomer having Formula V, Q.sub.1 and Q.sub.2 are each, independently, H, C.sub.1-C.sub.6 alkyl or substituted C.sub.1-C.sub.6 alkyl wherein at least one of Q.sub.1 and Q.sub.2 is other than H. 7. The oligomeric compound of claim 1 wherein for each monomer having Formula V, one of Q.sub.1 and Q.sub.2 is H and the other of Q.sub.1 and Q.sub.2 is C.sub.1-C.sub.6 alkyl or substituted C.sub.1-C.sub.6 alkyl. 8. The oligomeric compound of claim 7 wherein the other of Q.sub.1 and Q.sub.2 is CH.sub.3. 9. The oligomeric compound of claim 1 wherein for each monomer having Formula V, one of Q.sub.1 and Q.sub.2 is H and the other of Q.sub.1 and Q.sub.2 is CH.sub.2F, CHF.sub.2 or CF.sub.3. 10. The oligomeric compound of claim 1 wherein for each monomer having Formula V, Q.sub.1 and Q.sub.2 are each CH.sub.3. 11. The oligomeric compound of claim 1 wherein for each monomer having Formula V, Q.sub.1 and Q.sub.2 together are methylene (.dbd.CH.sub.2). 12. The oligomeric compound of claim 1 wherein for each monomer having Formula V, one of Q.sub.1 and Q.sub.2 is H, the other of Q.sub.1 and Q.sub.2 is CH.sub.3, one of Z.sub.1 or Z.sub.2 is H and the other of Z.sub.1 and Z.sub.2 is CH.sub.3. 13. The oligomeric compound of claim 1 wherein for each monomer having Formula V, Bx is uracil, thymine, cytosine, 5-methylcytosine, 2,6-diaminopurine, adenine or guanine. 14. The oligomeric compound of claim 1 wherein each internucleoside linking group is, independently, a phosphodiester or phosphorothioate. 15. The oligomeric compound of claim 1 wherein each internucleoside linking group is a phosphorothioate. 16. The oligomeric compound of claim 1 wherein for each monomer having Formula V, Z.sub.2 and Q.sub.2 are each H. 17. The oligomeric compound of claim 16 wherein Z.sub.1 and Q.sub.1 are each CH.sub.3 for each monomer having Formula V. 18. The oligomeric compound of claim 1 wherein Z.sub.2 and Q.sub.1 are each H for each monomer having Formula V. 19. The oligomeric compound of claim 18 wherein Z.sub.1 and Q.sub.2 are each CH.sub.3 for each monomer having Formula V. 20. The oligomeric compound of claim 1 wherein Z.sub.1 and Q.sub.2 are each H for each monomer having Formula V. 21. The oligomeric compound of claim 20 wherein Z.sub.2 and Q.sub.1 are each CH.sub.3 for each monomer having Formula V. 22. The oligomeric compound of claim 1 wherein Z.sub.1 and Q.sub.1 are each H for each monomer having Formula V. 23. The oligomeric compound of claim 22 wherein Z.sub.2 and Q.sub.2 are each CH.sub.3 for each monomer having Formula V. 24. The oligomeric compound of claim 1 comprising from about 8 to about 20 monomeric subunits. 25. The oligomeric compound of claim 1 comprising from about 10 to about 16 monomeric subunits. 26. The oligomeric compound of claim 1 comprising from about 10 to about 14 monomeric subunits. 